Lorenzo Pradella

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY.

CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC.

Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004.

Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.

Part of Thorne HealthTech, Inc., Thorne Research, Inc. manufactures natural dietary supplements and retails through online. The company is based in Summerville, SC. The company was founded in 1984 by Kelly Czap. Paul F. Jacobson has been the CEO of the company since 2010.

Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.

Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002.

Indena SpA provides research and development of medicinal products from plants. It offers products to the pharmaceutical, health-food, and personal care industries. The firm provides anti-cancer drugs, which are produced to US-FDA, ICH and EU standards and manufacturing facilities. The company was founded in 1921 and is headquartered in Milan, Italy.

Mandelli SpA engages in the distribution of motorcycle and bicycle parts, accessories, and gear. It operates through the following divisions: Bicycle-Fitness, Motorcycle, Toys, and GDO-Promotion. The Bicycle-Fitness division deals with workshop dealers, shops, and distribution chains. The Motorcycle division focuses on dealers, motorbike shops, and local distributors. The Toys division manages childcare stores, game shops, and toy chains. The GDO-Promotion division provides product marketing services. The company was founded by Riccardo Mandelli and Alfredo Mandelli in 1945 and is headquartered in Carate Brianza, Italy.

Helsinn Birex Pharmaceuticals Ltd. develops and manufactures oral dosage drug products. It is engaged in providing oral solid dosage forms and topical forms of pharmaceutical products and packaging of sterile products. The firm supplies its partners with ready to sell products on an exclusive basis, which are manufactured on site and using a network of external manufacturing partners. The company was founded by Gabriele Braglia on May 18, 1978 and is headquartered in Dublin, Ireland.

Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA.

Windham Venture Management LLC (Windham Venture Management) is a venture capital firm founded in 2006 by Joe Proto, Roger Fine and Adam Fine. The firm is headquartered in New York.

WellnessFX, Inc. provides online nutrition services for improving personal health. Its services include blood tests, phone consultations with health practitioners and intuitive online data tracking to measure cardiovascular, metabolic, hormonal and nutritional needs for health. The company was founded by Jim Kean and Brent Vaughan in 2010 and is headquartered in San Francisco, CA.

Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg.

Part of Helsinn Healthcare SA, Helsinn Advanced Synthesis SA develops and manufactures pharmaceutical ingredients. The company is based in Biasca, Switzerland.

3B Future Health Fund S.A. SICAR invest in companies located in Luxembourg. The fund targets companies operating in the fields of innovative technologies, cancer therapeutics & diagnostics, cancer supportive care, metabolic & gastrointestinal disorders, and dermatology conditions. It provides financing for early stage transactions.

QuantuMDx Group Ltd. develops devices for diagnostics detection. The firm offers DNA-XT, Under The Tree Diagnostics, Q-POC, and Internet of Life. The company was founded by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton in March 2008 and is headquartered in Newcastle upon Tyne, the United Kingdom.

GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

3B Future Health Fund II S.C. A. SICAV-RAIF invests in companies located in the US, Europe, Israel and Japan. The fund target companies operating in the fields of healthcare. It provides financing for early stage capital requirements with an investment up to USD 12 million. It also makes follow on investment and take a seat on the board of director.

Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies.

Confindustria Piacenza operates as a federation which represents, assists, and defends the interests of the manufacturing and service companies in the province of Piacenza in relation to all technical, economic, social, and cultural issues either on a national or international level. Its activities include the promotion of the sector; the improvement of working conditions of the represented businesses categories; and labor market development activities through social dialogue with the unions. The company is headquartered in Piacenza, Italy.